… aimed at treating certain cancers, was discovered by Akeso … Food and Drug Administration (FDA) approved its partner pharmaceutical company … Akeso, Inc.’s penpulimab-kcqx with cisplatin … or after platinum-based chemotherapy and with at …

… challenges such as poor pharmacokinetics, nonspecific biodistribution, … Indirect STING Activators Chemotherapeutic Drugs Unlike the aforementioned … bladder and ovarian cancers, cisplatin induces cGAS-STING … C, et al. Medicinal plant-derived mtDNA via …

… the development of pharmaceutical formulations, which will … the development of cancer, chemoresistance, and recurrence.118 … contributing significantly to medical progress. Translational research … extracellular vesicles to mediate cisplatin resistance. FASEB J …

… professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute, part … muscle-invasive bladder cancer was a combination of chemotherapy drugs, including cisplatin. This truly …

… April 23 by Akeso Pharmaceuticals Inc. related to … combination with platinum-based chemotherapy compared with Tevimbra ( … penpulimab in combination with cisplatin or carboplatin and … . BioWorld Clinical Regulatory Cancer Monoclonal antibody Asia-Pacific …

… new immunotherapy drug has been tested in combination with standard chemotherapy. Data … past week in combination with cisplatin or carboplatin and gemcitabine for … which are targets of certain cancer medications, between Hispanic and non-Hispanic …

… facilitating cisplatin clearance and reducing localized drug accumulation. … leveraging existing pharmacological agents to mitigate chemotherapy toxicity, … Nephropathies, Kidney cancer, Magnesium, Cancer research, Cisplatin, Chemotherapy, Acute kidney injury …

… list includes two crucial medications for cancer, like cisplatin and carboplatin. Experts reportedly … enormous drop in drug costs for American consumers. However, pharmaceutical companies see …

… limited, primarily relying on cisplatin-based chemotherapy, which is characterized by … immune checkpoint inhibitors, antibody-drug conjugates and novel exploratory therapies … , Maarten Albersen Center for Cancer Biology, Laboratory of Translational …

… in the division of renal medicine, director of onconephrology at Brigham … administration with cisplatin associated-AKI in patients with cancer undergoing cisplatin chemotherapy, investigators examined …